ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,761.00
0.77%
S&P ASX All Technology
3,066.90
-0.26%
Brent Oil
80.875
0.09%
US Dollar vs AUD
1.50619
0.51%
Bitcoin
69,085.70
1.97%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DateTimeSourceHeadlineSymbolCompany
30/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International ConventionNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/05/202407:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/05/202407:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/05/202407:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/05/202407:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/05/202407:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
22/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
22/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/05/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
15/05/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/05/202406:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/05/202406:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/05/202406:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/05/202406:30GlobeNewswire Inc.Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/04/202422:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at Planet MicroCap ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/04/202407:15GlobeNewswire Inc.Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/03/202400:32GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at BIO-Europe SpringNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/03/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/03/202423:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/03/202401:37GlobeNewswire Inc.New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/03/202400:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Your Recent History

NYSE
DIS
Walt Disney
ASX
CBA
Commonwealth Bank Of Aus...
ASX
BHP
BHP
ASX
WPL
Woodside Petroleum
ASX
RIO
Rio Tinto
ASX
XFL
S&P ASX 50
FX
AUDUSD
AUD vs US Dollar
FX
AUDJPY
AUD vs Yen
FTSE
UKX
FTSE 100
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NASDAQ
TSLA
Tesla
ASX
SUN
Suncorp
FX
GBPAUD
Sterling vs AUD
ASX
ORG
Origin Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved